Evaluation of retinol binding protein 4 and carbamoylated haemoglobin as potential renal toxicity biomarkers in adult mice treated with 177Lu-octreotate

Radionuclides in Nephrourology, Part 1: Radiopharmaceuticals, Quality Control, and Quantitative Indices

(2014) A. T. Taylor   JOURNAL OF NUCLEAR MEDICINE

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

(2013) John J. Zaknun et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Renal and Hematological Toxicity in Patients of Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE

(2012) Santosh K. Gupta et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Established and Emerging Markers of Kidney Function

(2012) M. A. Ferguson et al.   CLINICAL CHEMISTRY

Radionuclide Therapy via SSTR: Future Aspects from Experimental Animal Studies

(2012) Eva Forssell-Aronsson et al.   NEUROENDOCRINOLOGY

Nephrotoxicity profiles and threshold dose values for [177Lu]-DOTATATE in nude mice

(2012) Johanna Svensson et al.   NUCLEAR MEDICINE AND BIOLOGY

Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy

(2012) Maria Larsson et al.   EJNMMI Research

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

(2011) Lisa Bodei et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [177Lu-DOTA0,Tyr3]Octreotate

(2011) S. Khan et al.   JOURNAL OF NUCLEAR MEDICINE

A New General Pathway for Synthesis of Reference Compounds of N-Terminal Valine−Isocyanate Adducts

(2010) Ronnie Davies et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention

(2010) E. Vegt et al.   JOURNAL OF NUCLEAR MEDICINE

Towards a knowledge-based Human Protein Atlas

(2010) Mathias Uhlen et al.   NATURE BIOTECHNOLOGY

Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

(2010) Dik J. Kwekkeboom et al.   SEMINARS IN NUCLEAR MEDICINE

[177Lu-DOTA0-Tyr3]-Octreotate Treatment in Patients with Disseminated Gastroenteropancreatic Neuroendocrine Tumors: The Value of Measuring Absorbed Dose to the Kidney

(2010) Christina Swärd et al.   WORLD JOURNAL OF SURGERY

In vitro comparison of renal handling and uptake of two somatostatin receptor-specific peptides labeled with indium-111

(2009) Frantisek Trejtnar et al.   ANNALS OF NUCLEAR MEDICINE

Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins

(2008) Hiromichi Akizawa et al.   ADVANCED DRUG DELIVERY REVIEWS

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

(2008) Lisa Bodei et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Expression of Somatostatin and Somatostatin Receptor Subtypes 1–5 in Human Normal and Diseased Kidney

(2008) Sunil Bhandari et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Isoforms of Retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver

(2008) Simone K Frey et al.   Lipids in Health and Disease

Biomarkers of Acute Kidney Injury

(2007) Vishal S. Vaidya et al.   Annual Review of Pharmacology and Toxicology